Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayle Overend

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
Transport proteins NHA1 and NHA2 are essential for survival, but have distinct transport modalitiesVenkateswara R Chintapalli, Akira Kato, Louise Henderson, et al.
Peptides|September 7, 2011
The receptor guanylate cyclase Gyc76C and a peptide ligand, NPLP1-VQQ, modulate the innate immune IMD pathway in response to salt stressGayle Overend, Pablo Cabrero, Andy Xin Guo, et al.
Human Mutation|October 15, 2019
A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotypeAlfonsina Ballester-Lopez, Emma Koehorst, Miriam Almendrote, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
Transport proteins NHA1 and NHA2 are essential for survival, but have distinct transport modalitiesVenkateswara R Chintapalli, Akira Kato, Louise Henderson, et al.
Peptides|September 7, 2011
The receptor guanylate cyclase Gyc76C and a peptide ligand, NPLP1-VQQ, modulate the innate immune IMD pathway in response to salt stressGayle Overend, Pablo Cabrero, Andy Xin Guo, et al.
Human Mutation|October 15, 2019
A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotypeAlfonsina Ballester-Lopez, Emma Koehorst, Miriam Almendrote, et al.
Pageof 2